The two companies named as defendants distribute Cold-FX products in Canada, the law firm said in a news release following the certification.
The product claims highlighted in the suit include "proven by science," and "clinically proven," as well as that they contain "clinically proven ingredients," or have a "clinically proven formula" to help reduce frequency, duration and severity of cold and flu symptoms. "The Defendants deny that they have made any false, misleading or deceptive statements in relation to COLD-FX Products and deny that they have breached any of the legislation referred to," the firm said in its news release.Those eligible to be included in the class action must have purchased one or more of the following Cold-FX products between Jan. 1, 2017, and Sept. 28, 2023, in Canada.
Россия Последние новости, Россия Последние новости
Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей
Источник: blogTO - 🏆 44. / 63 Прочитайте больше »